Search

everythinglearnresearchcommunity

for

Search:↓

The research confirms that Hidradenitis Suppurativa is characterized by increased inflammation, disrupted skin cell organization, and abnormal metabolic processes.

Skin cells release substances important for healing and fighting infection, and understanding these could improve skin disorder treatments.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

DCPA is a chronic skin condition affecting the legs, often misdiagnosed, and needs more research for better understanding and treatment.

Understanding how acne develops in different diseases could lead to new treatments.

The chapter explains common scalp conditions, including infections, infestations, and tumors.

Exosomes could be key in treating skin conditions and healing wounds.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

A woman developed psoriasis after taking certolizumab pegol, improving after stopping the drug and starting other treatments.

Calcipotriol treatment for scalp psoriasis does not cause hair loss.

The new gel combining calcipotriene and betamethasone is effective and safe for treating scalp psoriasis.

The study found no link between vitamin D deficiency and psoriasis but suggests more research is needed.

Retinoids help treat psoriasis effectively, but they can cause side effects and need more research on safe use with other treatments.

Retinoids are effective for skin conditions like severe acne and psoriasis but must be used with caution due to potential side effects and risks during pregnancy.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

Topical minoxidil showed promise for early male pattern baldness.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

A woman with severe hair loss was successfully treated with the drug adalimumab.

Triple horizontal scalp biopsies are 98% accurate in diagnosing hair loss, better than single biopsies.

The document suggests a possible connection between rapid weight loss and hair loss, and reports a case of skin condition improvement after stopping acne medication.

Sudden weight loss can cause significant hair loss, and using colchicine on the skin for psoriasis may be unsafe.

Stopping adalimumab and starting methotrexate with topical treatments improved the woman's scalp psoriasis and hair regrew.

Coal tar shampoos, salicylic acid, and topical corticosteroids are effective for scalp psoriasis, with Vitamin D3 analogues also showing benefits; severe cases may require stronger medication with more risks.

Stopping the medication infliximab and starting new treatments helped a woman's hair grow back and improved her scalp condition.

A rare scalp condition mainly in older women can be treated with various alternatives to steroids, which may have fewer side effects.

EPDS and MS might share an immune-related cause.

Docetaxel, a chemotherapy drug, was reported to cause psoriasis in a patient for the first time.